But Bellito also knew that AstraZeneca got related drugs (osimertinib) to cooperative laboratories in other countries on the pretext of cooperating with clinical trials. This was the company's private behavior, and they really didn't want to do it.
What can I say?
After all, AstraZeneca is a multinational pharmaceutical company, not just an American pharmaceutical company.
Bellito's department can only issue warnings, fines and other measures against AstraZeneca, but what's the use?
Bellito called the team members angrily, and he wanted to go to AstraZeneca's headquarters in person!
Xia Kingdom, Changzezhou.
Qu Ping placed a box of osimertinib in front of Chen Xiao.
Chen Xiao has seen this medicine before.
Before rebirth, Chen Xiao's grandfather Chen Jinsong in parallel time and space suffered from lung cancer and took this medicine.
At that time, this drug was not domestically produced, and there was no cooperation agreement with AstraZeneca to introduce it, so Chen Xiao had to buy it from the United States at a high price through personal relationships.
At that time, one tablet (80 mg) cost 1,700 yuan. If you take one tablet a day, the monthly cost would be as high as 51,000 yuan.
Fortunately, Chen Xiao's financial situation is good and he can afford it.
Grandpa did extend his life by several years through this medicine.
But Chen Xiao knew very well that there were thousands of people in Xia who couldn't afford this medicine and could only wait to die in bed.
Later, the country introduced the drug to the United States through negotiations, and the price was reduced to 510 yuan per piece. The monthly cost of taking osimertinib was 15,300 yuan. After being reimbursed by medical insurance, the monthly cost borne by the patient was 4,590 yuan.
This price is much cheaper than a few years ago, but it is still very expensive for many Xia people.
Especially around 2020, nearly 43% of households in Xia State have a per capita monthly income of less than 1,090 yuan, 56.5% of the population have a per capita monthly household income of less than 1,500 yuan, and 69% of the population have a per capita monthly household income of less than 2,000 yuan. Also
That is to say, the per capita monthly income of most people in the country is less than 2,000 yuan.
This kind of medicine costs up to 4,590 yuan per month, even if it is reimbursed by medical insurance, it is still unaffordable.
Therefore, Chen Xiao was still filled with emotion when seeing such medicine.
Chen Xiao said to Qu Ping: "Send the medicine to the medical team to see how to treat He Jiang."
Osimertinib has a very good effect on brain metastases from lung cancer, so even though He Jiang's lungs have been removed, there are still brain metastases and kidney metastases.
There is definitely no problem with using this drug.
Chen Xiao added: "If some drugs are sent to the laboratory, Asan can prevent them. We can optimize the drugs on the basis of imitation and circumvent their patented technology. There should be no problem."
"By the way, let's inform the Shanghai Stock Exchange and Yanjing City so that they don't get anxious."
Chen Xiao also saw the media reports in the past few days about He Jiang's condition and the inability to get medicine.
The reason why the relevant media reported this matter at this time is actually because they did not have any hope for He Jiang's treatment.
Qu Ping immediately followed what Chen Xiao said.
Yanjing and Xie Fei received a call from Changtian Technology and were told that osimertinib has been used in He Jiang's clinical treatment.
After getting the news, Xie Fei was shocked!
Xie Fei used all available private and public relations, but failed to get the medicine, and the other party's response was very tough.
Xie Fei recognized all of this!
Who says that our country's medical technology is inferior to that of the United States?
Those who fall behind will be beaten. This has been true since ancient times.
He did not expect that Changtian Technology could obtain the medicine so easily.
Xie Fei was even more shocked when he learned that Changtian Technology required many pharmaceutical companies to supply immediately at the expense of business in the Americas!
You know, Changtian Technology is just a private company.
A private company does not need to ask the other party to have a strong sense of national, national and historical responsibility. After all, the other party wants to make money.
In order to buy medicines, Xie Fei went to many state-owned pharmaceutical companies that had business dealings with AstraZeneca. However, the other parties either lacked the ability or were afraid of damaging their relationship with AstraZeneca, so they went to various sources.
There are no excuses to avoid.
Only Changtian Technology can stand up at the first time and use its annual business of hundreds of millions of yuan as a bargaining chip to negotiate with the other party.
And Xie Fei knew very well that this matter had nothing to do with Changtian Technology.
He Jiang suffered from small cell lung cancer, not pulmonary fibrosis or other severe lung diseases. Changtian Technology Intensive Treatment Center is not a professional hospital for cancer treatment.
However, Changtian Technology still stepped forward without hesitation and completed such an arduous task.
Xie Jiang felt very uncomfortable!
Fortunately, Changtian Technology is a technology company of Xia State, not an American or Japanese company.
If Changtian Technology were an overseas company, what a formidable competitor it would be!
Xie Fei immediately sat in front of the computer and wrote a report himself, reporting to the superiors the relevant situation of Changtian Technology's acquisition of osimertinib.
Such companies must be given significant policy and economic support conditions.
Xie Fei even felt that there was no hope of relying on state-owned research institutes to develop anti-cancer drugs like osimertinib, and he could only rely on Changtian Technology.
Xie Fei has spent time in state-owned research institutes, and he has done the same thing regardless of whether he does a lot of work or a little, and his laziness is quite serious.
Under such circumstances, only fools will have the spirit of scientific research and innovation. It is true that they can do less work and make more money. Who will really put effort into scientific research?
Xie Fei knows this situation too well!
On the contrary, Changtian Technology is more dynamic than many state-owned research institutes.
The news that Changtian Technology had obtained the drug was soon known to the media. Many media, which had been paying attention to He Jiang's follow-up situation, asked Changtian Technology to confirm whether it had obtained osimertinib.
In the past few days, there have been a large number of reporters either crowded in the press reception room of the critical care center, or frantically calling Changtian Technology for verification.
Seeing reporters being so enthusiastic, Qu Ping held a brief press conference only after seeking Chen Xiao's opinion in order to ensure the normal working order of the treatment center.
"Hello, Director Qu, has Changtian Technology found a way to obtain osimertinib?"
"Director Qu, national radio and television reporter, Xu Tao. How did Changtian Technology obtain osimertinib? Has the drug been used for Mr. He's treatment?"
"Director Qu, I am a reporter from Xinlang.com. As far as we know, AstraZeneca has banned the sale or donation of osimertinib to any country, individual or organization in the world. How did Changtian Technology obtain it?
drug? What is the current therapeutic effect of this drug?"
In fact, Qu Ping felt very unhappy when she organized this press conference.
When has it been?
The medical team in the critical care center was scrambling to save the patient's life, while the reporters here were concerned about where the medicine came from.
Qu Ping didn't look good and said: "Reporters have asked a lot of questions, so I won't answer them one by one. The medicine was obtained by Changtian Technology through certain efforts, and the treatment is currently in progress. I hope the reporters can give the treatment team
For a certain period of time, we will also give Mr. He a quiet therapeutic environment."
After Qu Ping gave a simple answer, the reporters at the scene cheered and applauded, and talked excitedly.
"Changtian Technology still has a solution!"
"That's right, many departments have tried various methods but they still can't get it as soon as Yaochangtian Technology comes out."
"It will be easier once the medicine comes back! The effect should be very powerful. I have seen some experimental data from AstraZeneca. Osimertinib has a very good effect on lung cancer metastasis to the brain."
Qu Ping was quite surprised.
This group of reporters actually applauded.
Both Chen Xiao and Qu Ping think it is shameful for Xia people to try their best to seek medicine overseas. What the hell are these people actually applauding?
Do you want to celebrate the other person giving you some anti-cancer drugs?
Qu Ping pressed her hands and said with a bad expression: "I don't think it is something to be proud of that so many scientific research institutions and pharmaceutical companies in our country cannot produce corresponding anti-cancer drugs. Today's press conference is here
Here, thank you everyone."
After Qu Ping dropped these words, she left the conference room, leaving the reporters looking at each other.
Some of the reporters were blushing, and suddenly felt that what Qu Ping said made sense.
What are you excited about?
Are you happy because of a little charity from Western companies?
The medicine was not produced in Xia State, nor was it purchased through normal trade. What is there to be happy about?
Looking at Qu Ping's leaving figure, the reporters suddenly gained some profound understanding of Changtian Technology.
They felt that this private company was different from the companies they had known before.
In the past, especially some hospitals or scientific research centers, if they had encountered the same situation as He Jiang, they would have tried every possible means to buy osimertinib from AstraZeneca.
They must be rushing to hold press conferences and claiming credit. They feel that being able to buy drugs from AstraZeneca is a great merit. They must make big reports and special reports, and even wear red flowers with merit medals.
Changtian Technology’s approach is completely different from theirs.
This time, Changtian Technology almost single-handedly suppressed its own medical industry in Mizhou. Only then was it able to get the American pharmaceutical giants to compromise and obtain relevant drugs.
But Changtian Technology never thinks that this is a good thing, but a particularly shameful thing.
Because Xia Guo's technology company is not strong, it cannot rely on its own capabilities to produce anti-cancer drugs comparable to osimertinib.
Because Xia Guo is not strong enough, we have many research institutes and considerable scientific research funding, but we don’t even have a pharmaceutical company to replace AstraZeneca.
This idea makes many journalists feel ashamed.
"Changtian Technology hopes that anti-cancer drugs will no longer be purchased abroad!" Half an hour later, Xinlang used this as the title and reported the entire interview with Changtian Technology's press conference on the front page.
The content of the report basically restored the entire process of the press conference. At the end of the report, the commentator of Xinlang sighed:
"Changtian Technology is not excited because it has overcome all obstacles and purchased osimertinib. Instead, it is frustrated because no domestic pharmaceutical company can produce anti-cancer drugs similar to osimertinib!
We hope that more Xiaguo scientific research companies will come forward. We hope that next time we need similar drugs, a Xiaguo science and technology company can provide domestically produced drugs as quickly as possible, instead of trying every means to ask for drugs.
Therefore, he is abroad."
Not only was it a wave of emotion, many media reporters who attended the Changtian Technology press conference had different feelings.
Xinlang, who followed one after another, reported the relevant situation.
Netizens were very surprised when they saw Changtian Technology’s press conference.
Because Changtian Technology was able to obtain osimertinib through its own channels, which is already a very remarkable thing.
However, Changtian Technology did not take credit as much as everyone imagined. Instead, it felt guilty for not being able to develop similar drugs.
This pursuit of excellence in science and technology is exactly what many scientific research institutions in Xia State lack.
Fei also saw relevant media reports and took a sip of tea silently.
This is the scientific research company that Xia Kingdom needs.
After He Jiang received treatment, his condition became stable.
But no one can guarantee that the tumor will not spread or metastasize.
Everyone can only hope that after the condition stabilizes, the lesions will gradually shrink and eventually disappear.
After He Jiang completed the combined colony transplantation and lung resection surgery, he was able to sit on the bed and whisper something.
This time Chen Xiao and Qu Ping went to visit him, and the leaders and colleagues of Institute 606 happened to be there too.
He Jiang's students and subordinates held notebooks and listened to every word of He Jiang's explanation.
He Jiang said: "Although our engine can be installed on the aircraft, it still has some defects."
"One is that when the temperature in front of the vortex reaches 1500K, the efficiency will be reduced by 10%. The other is that if thrust is added, the fuel efficiency will be reduced to 60%, which cannot reach our combat radius of 1200-1500km. Our design thrust is 17 tons.
The actual thrust is less than 12 tons."
"I...my latest data shows..." He Jiang gasped for air.
"Teacher, don't be anxious, speak slowly."
The students quickly handed the water to He Jiang.
After He Jiang had his lungs removed, he relied on his chest diaphragm to produce his voice, so his voice sounded strange and difficult.
He Jiang took a sip of water and calmed down after a while and said: "At present, the overhaul time of Turbofan 10 is less than 1,000 hours, and the usage efficiency is too low..."
"Due to technical reasons, we haven't been able to match the thrust loss nozzle..."
The students stopped hearing He Jiang's words and were very disappointed.
They all thought that the turbofan 10 had been successful after decades of research, but they did not expect that there were so many detailed issues. The students had known these things before, but being reminded repeatedly by He Jiang on this occasion made everyone feel uncomfortable.
.
At this time, Chen Xiao said: "The turbofan-10 uses a three-stage fan, nine-stage rectification, one-stage high pressure, and one stage low pressure, which is the so-called 3+9+1+1 structure with high thrust, high thrust-to-weight ratio, and low bypass ratio.
engine."
"But with the current thrust, if it is equipped with a displacement nozzle, not only will it not be able to increase speed in an emergency, but it will easily cause a stall. The reason is that the thrust is still insufficient."
When Chen Xiao said this, everyone turned their heads.